PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Bristol-Myers Squibb Co's PE Ratio without NRI is 24.90. Bristol-Myers Squibb Co's 5-Year EBITDA growth rate is 8.00%. Therefore, Bristol-Myers Squibb Co's PEG Ratio for today is 3.11.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Bristol-Myers Squibb Co's PEG Ratio or its related term are showing as below:
BMY'
s PEG Ratio Range Over the Past 10 Years
Min: 0.54 Med: 2.01 Max: 12.84
Current: 3.12
During the past 13 years, Bristol-Myers Squibb Co's highest PEG Ratio was 12.84. The lowest was 0.54. And the median was 2.01.
BMY's PEG Ratio is ranked worse than 70.6% of 364
companies
in the Drug Manufacturers industry
Industry Median: 1.60
vs BMY: 3.12
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Bristol-Myers Squibb Co PEG Ratio Historical Data
The historical data trend for Bristol-Myers Squibb Co's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Bristol-Myers Squibb Co Annual Data
Trend
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
PEG Ratio
4.69
1.04
1.34
-
5.34
Bristol-Myers Squibb Co Quarterly Data
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
PEG Ratio
-
-
5.34
3.47
2.24
Competitive Comparison
For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bristol-Myers Squibb Co PEG Ratio Distribution
For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Bristol-Myers Squibb Co's PEG Ratio falls into.
Bristol-Myers Squibb Co PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
Bristol-Myers Squibb Co's PEG Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Bristol-Myers Squibb Co (NYSE:BMY) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Bristol-Myers Squibb Co PEG Ratio Related Terms
Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
1.16(1.57%) Volume: 8,978,600 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:BMY has been successfully added to your 
